ARTICLE | Clinical News
Aloxi regulatory update
January 25, 2010 8:00 AM UTC
Japan approved Aloxi palonosetron to prevent chemotherapy-induced nausea and vomiting (CINV) in patients with cancer. Taiho Pharmaceutical Co. Ltd., a subsidiary of Otsuka Holdings Co. Ltd. (Tokyo:4...